CT UK Capital and Income AGM 2023

The AGM will be followed by a presentation by Julian Cane on the company and its investment portfolio.

For Shareholders who are unable to attend, any questions they may have regarding the resolutions proposed at the AGM or the performance of the Company can be directed to a dedicated email account, ctukagm@columbiathreadneedle.com, by Thursday 2 March 2023. We will endeavour, in so far as reasonably practicable, to address all such questions at the meeting. In addition, the meeting will be recorded and will be available to view on the Company’s website, www.ctukcapitalandincome.com shortly thereafter.

To ensure that your votes will count, I would encourage all Shareholders that cannot attend in person to complete and submit their Form of Proxy or Form of Direction in advance of the AGM.

Continuation Vote

In accordance with the Company’s articles of association, every five years the Board seeks Shareholder approval for the continuation of the Company. As the last vote occurred in 2018, an ordinary resolution for the continuation of the Company will be proposed at the forthcoming AGM. The Board believes that it is in the best interests of Shareholders for the Company to continue and therefore encourages Shareholders to vote in favour of the Company’s continuation.

 During the year the Board surveyed investors who hold the Company’s shares within the CT Savings Plans. The purpose of the survey was to gain a deeper understanding of investors’ views and sentiment towards the Company in advance of the continuation vote. Common themes amongst responses included the importance of performance, dividend growth, low fees and the reputation of the Manager. The Board has noted that most respondents invest for the longer-term with retirement and income being key reasons for investment.

 I would like to thank on behalf of the Board the many investors who took the time to complete the survey and provide comments and questions. The Board has considered these results and comments and is taking steps to address the issues raised.

 Your stated priorities are fully aligned with your Board’s and we shall continue to pursue them on behalf of Shareholders.